AZTA
Azenta Inc
NASDAQ: AZTA · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$23.13
-4.58% today
Updated 2026-04-29
Market cap
$1.07B
P/E ratio
39.88
P/S ratio
1.79x
EPS (TTM)
$0.58
Dividend yield
—
52W range
$20 – $42
Volume
0.9M
WallStSmart proprietary scores
57
out of 100
Grade: C+
Hold
Investment rating
6.0
Growth
B8.5
Quality
A2.5
Profitability
F7.3
Valuation
B+5/9
Piotroski F-Score
Moderate
4.7
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$35.40
+53.05%
12-Month target
$21.75
-5.97%
Intrinsic (DCF)
$53.08
Margin of safety
+42.63%
2 Strong Buy2 Buy3 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Altman Z 4.65 — safe zone
+ Free cash flow $14.65M — positive
+ 42.63% below intrinsic value
+ Debt/equity 0.06x — low leverage
Risks
- Thin margins at -10.10%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $555.50M | $665.07M | $573.45M | $593.82M | $595.03M |
| Net income | $-428.96M | $-14.26M | $-164.90M | $-55.76M | $-15.43M |
| EPS | — | — | — | — | $0.58 |
| Free cash flow | $-543.48M | $-33.60M | $12.35M | $38.32M | $14.65M |
| Profit margin | -77.22% | -2.14% | -28.76% | -9.39% | -10.10% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-02-06 | NOVA, TINA SUSAN | Buy | 5,663 | $27.85 |
| 2026-02-05 | MCLAUGHLIN, ERICA | Buy | 5,663 | $27.85 |
| 2026-02-05 | MADAUS, MARTIN D | Buy | 5,663 | — |
Peer comparison
Smart narrative
Azenta Inc trades at $23.13. representing a P/E of 39.88x trailing earnings. Our Smart Value Score of 57/100 indicates the stock is fair. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 4.65, it sits in the safe zone. TTM revenue stands at $595.03M. with profit margins at -10.10%. Our DCF model estimates intrinsic value at $53.08.
Frequently asked questions
What is Azenta Inc's stock price?
Azenta Inc (AZTA) trades at $23.13.
Is Azenta Inc overvalued?
Smart Value Score 57/100 (Grade C+, Hold). DCF value $53.08.
What is the price target of Azenta Inc (AZTA)?
The analyst target price is $35.40, representing +53.0% upside from the current price of $23.13.
What is the intrinsic value of Azenta Inc (AZTA)?
Based on our DCF model, intrinsic value is $53.08, a +42.6% margin of safety versus $23.13.
What is Azenta Inc's revenue?
TTM revenue is $595.03M.
Piotroski F-Score?
5/9 — moderate financial health.
Altman Z-Score?
4.65 — safe zone.
Company info
SectorHEALTHCARE
IndustryMEDICAL INSTRUMENTS & SUPPLIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.79x
ROE1.53%
Beta1.47
50D MA$23.90
200D MA$30.41
Shares out0.05B
Float0.04B
Short ratio—
Avg volume0.9M
Performance
1 week+13.72%
1 month-6.87%
3 months-32.23%
YTD-31.96%
1 year—
3 years—
5 years—